SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-298277
Filing Date
2021-10-14
Accepted
2021-10-14 07:15:42
Documents
15
Period of Report
2021-10-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d212374d8k.htm   iXBRL 8-K 33536
2 EX-10.1 d212374dex101.htm EX-10.1 69363
3 EX-99.1 d212374dex991.htm EX-99.1 7295
7 GRAPHIC g212374g1013042856765.jpg GRAPHIC 2845
  Complete submission text file 0001193125-21-298277.txt   261199

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA crsp-20211014.xsd EX-101.SCH 2892
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20211014_lab.xml EX-101.LAB 17306
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20211014_pre.xml EX-101.PRE 10929
8 EXTRACTED XBRL INSTANCE DOCUMENT d212374d8k_htm.xml XML 3263
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 211322480
SIC: 2836 Biological Products, (No Diagnostic Substances)